Venture Valuations Biotechgate Collaborates with California Life Sciences Association (CLSA) to Connect California’s Life Sciences Sector

Zurich, Bay Area & San Diego, CA – August 2017 – California Life Sciences Association (CLSA), the premier public policy advocacy and business leadership trade association representing California’s life sciences industry, and Venture Valuations Biotechgate, a global Life Sciences database today announced their collaboration to create an in-depth member directory for CLSA as well as a … Continue reading Venture Valuations Biotechgate Collaborates with California Life Sciences Association (CLSA) to Connect California’s Life Sciences Sector

Read more

Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School. The online event was a part of Healthcare Roundtable, a series of interactive presentations by industry leaders organised by HBS Healthcare Alumni Association. Dr. Frei talked about the significance … Continue reading Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

Read more

What is the value of a deal?

Venture Valuations Dr. Aitana Peire and Dr. Patrik Frei have published an article “What is the value of a deal?” in Nature Publishing Groups’ biopharmadealmakers.nature.com. The article is available online as well as in the biopharmadealmakers supplement June 2016 edition of nature biotechnology and Nature Reviews Drug Discovery. The pharmaceutical and biotechnology industries see over … Continue reading What is the value of a deal?

Read more